Form 4: Arrow Financial Corp Director Philip C Morris Acquires Shares

Sentiment:

SEC Form 4 Filing


Director Philip C Morris acquired 271 shares of Arrow Financial Corp common stock on April 9, 2025, at a price of $25.37 per share.

Summary

  • On April 9, 2025, Philip C Morris, a director of Arrow Financial Corp, acquired 271 shares of common stock at $25.37 per share.
  • The transaction was reported on a Form 4 filing with the SEC.
  • Following the transaction, Morris directly owns 5,294 shares of Arrow Financial Corp.
  • The filing also notes that 119 shares were acquired under the Company's DRIP since January 29, 2025, which were not required to be reported on a Form 4 but are being disclosed for total holdings.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard regulatory filing indicating a director's share acquisition. It doesn't inherently convey positive or negative information about the company's performance.

Positives

  • Director's acquisition of shares may signal confidence in the company's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. It is difficult to assess the significance of this transaction without broader context of similar transactions.

Key Dates

DateDescription
01/29/2025Date from which 119 shares were acquired under the Company's DRIP.
04/09/2025Date of the transaction where Philip C Morris acquired 271 shares.
04/10/2025Date of the Form 4 filing.

Keywords

Form 4, insider trading, share acquisition, Philip C Morris, Arrow Financial Corp, AROW, director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.